Polyrizon partners with Clearmind to develop intranasal MEAI formulation

Go back to Polyrizon partners with Clearmind to develop intranasal MEAI formulation
(NASDAQ: CMND) Delayed: 2.91 --0 (-0%)
Previous Close $2.91    52 Week High
Open $2.87    52 Week Low
Day High $3.00    P/E N/A 
Day Low $2.84    EPS
Volume 126,172       

(NASDAQ: PLRZ) Delayed: 12.80 -0.66 (4.9%)
Previous Close $13.46    52 Week High
Open $13.53    52 Week Low
Day High $13.92    P/E N/A 
Day Low $12.80    EPS
Volume 26,430